Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Antibiotic Guidelines for Ophthalmological Indications in Secondary Care: Microbiology, Lecture notes of Ophthalmology

Antibiotic guidelines for various ophthalmological indications in secondary care settings. It covers symptoms, diagnosis, and treatment for different types of eye infections, including blepharitis, conjunctivitis, keratitis, and endophthalmitis. The guidelines also include information on version control, other relevant guidelines, and risk factors for developing infections.

What you will learn

  • What are the symptoms of herpes zoster ophthalmicus?
  • How is posterior marginal blepharitis treated?
  • How is herpes zoster ophthalmicus treated?
  • What are the risk factors for developing eye infections?
  • What are the symptoms of anterior and posterior marginal blepharitis?

Typology: Lecture notes

2021/2022

Uploaded on 09/27/2022

fuller
fuller 🇬🇧

4.8

(6)

241 documents

1 / 67

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Antibiotic Guidelines for Ophthalmological Indications in Secondary Care
Microbiology
Page 1 of 67
Document Control
Title
Antibiotic guidelines for ophthalmological indications in Adults in
Secondary Care
Author
Author’s job title
Consultant Microbiologist
Consultant Ophthalmologist
Pharmacist
Directorate
Diagnostics
Department
Microbiology
Version
Date
Issued
Status
Comment / Changes / Approval
0.1
Jan
2011
Draft
First draft for consultation. After discussion with Mr
Nestel. Further discussion with Ophthalmology.
Changes to prophylaxis after penetrating injury.
Changes to keratitis. Change to prophylaxis for
globe injury
1.0
Sep
2011
Final
Approved by DTG with minor amendments.
1.1
Sep
2011
Revision
Minor amendments to document control report, hyperlinks
to appendices, and added headers and footers. Automatic
table of contents. Change of co-amoxiclav frequency for
pre-orbital cellulitis.
1.3
Jan
2012
Revision
Corrected hyperlinks to Vancomycin guideline in
appendices.
1.4
Feb
2012
Revision
Change from cefuroxime to cefotaxime for orbital cellulitis
to bring into line with published guidance.
2.0
Mar
2012
Final
Approved by Drug and Therapeutics Committee on 8th
March 2012 with minor amendments.
2.1
Jun
2012
Revision
Minor amendment by Corporate Governance to document
control report.
2.2
Nov
2012
Revision
Minor changes to preparations (preservative free) and
dosing intervals for keratitis
2.3
Mar
2013
Revision
Keratitis changed to preservative free drops.
2.4
Jun
2017
Revision
Guidance split into two: treatment and surgical
prophylaxis. Added acanthamoeba guidance.
3.0
May
2019
Final
Reviewed with Consultant Ophthalmologist. Information for
intra-vitreal preparations deleted, to refer to on-site manual
in theatres. Anti-fungal guidance added for keratitis,
endophthalmitis, penetrating globe injury. Clinical
diagnostics information added for all indications as per
updated NICE requirements for antibiotic guidelines.
References updated. Approved at DTC 16th May 2019.
Main Contact
Consultant Microbiologist
Microbiology
North Devon District Hospital
Raleigh Park
Barnstaple, EX31 4JB
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20
pf21
pf22
pf23
pf24
pf25
pf26
pf27
pf28
pf29
pf2a
pf2b
pf2c
pf2d
pf2e
pf2f
pf30
pf31
pf32
pf33
pf34
pf35
pf36
pf37
pf38
pf39
pf3a
pf3b
pf3c
pf3d
pf3e
pf3f
pf40
pf41
pf42
pf43

Partial preview of the text

Download Antibiotic Guidelines for Ophthalmological Indications in Secondary Care: Microbiology and more Lecture notes Ophthalmology in PDF only on Docsity!

Microbiology

Document Control

Title

Antibiotic guidelines for ophthalmological indications in Adults in

Secondary Care

Author Author’s job title Consultant Microbiologist Consultant Ophthalmologist Pharmacist Directorate Diagnostics

Department Microbiology Version Date Issued Status^ Comment / Changes / Approval 0.1 Jan 2011

Draft First draft for consultation. After discussion with Mr Nestel. Further discussion with Ophthalmology. Changes to prophylaxis after penetrating injury. Changes to keratitis. Change to prophylaxis for globe injury 1.0 Sep 2011

Final Approved by DTG with minor amendments.

  1. 1 Sep 2011

Revision Minor amendments to document control report, hyperlinks to appendices, and added headers and footers. Automatic table of contents. Change of co-amoxiclav frequency for pre-orbital cellulitis. 1.3 Jan 2012

Revision Corrected hyperlinks to Vancomycin guideline in appendices. 1.4 Feb 2012

Revision Change from cefuroxime to cefotaxime for orbital cellulitis to bring into line with published guidance. 2.0 Mar 2012

Final Approved by Drug and Therapeutics Committee on 8th March 2012 with minor amendments. 2.1 Jun 2012

Revision Minor amendment by Corporate Governance to document control report. 2.2 Nov 2012

Revision Minor changes to preparations (preservative free) and dosing intervals for keratitis 2.3 Mar 2013

Revision Keratitis – changed to preservative free drops.

2.4 Jun 2017

Revision Guidance split into two: treatment and surgical prophylaxis. Added acanthamoeba guidance. 3.0 May 2019

Final Reviewed with Consultant Ophthalmologist. Information for intra-vitreal preparations deleted, to refer to on-site manual in theatres. Anti-fungal guidance added for keratitis, endophthalmitis, penetrating globe injury. Clinical diagnostics information added for all indications as per updated NICE requirements for antibiotic guidelines. References updated. Approved at DTC 16th^ May 2019. Main Contact Consultant Microbiologist Microbiology North Devon District Hospital Raleigh Park Barnstaple, EX31 4JB

Tel: Direct DialTel: InternalEmail :

Microbiology

Lead Director Director of Medicine Superseded Documents Antibiotic Guidelines for Ophthalmology v1.8 290413 Issue Date May 2019

Review Date May 2022

Review Cycle Three years Consulted with the following stakeholders:

 Antibiotic Working Group  Drug & Therapeutics Group  Consultant Ophthalmologists

Approval and Review Process  Antibiotic Working Group  Drug & Therapeutics Group

Local Archive Reference G:\ANTIBIOTICSTEWARDSHIP Local Path G:\ANTIBIOTIC STEWARDSHIP\Stewardship\Antibiotic policies\Published policies Filename Antibiotic Guidelines for Ophthalmology v2.0 160519 Policy categories for Trust’s internal website (Bob) Pharmacy, Microbiology, Ophthalmology

Tags for Trust’s internal website (Bob) Conjunctivitis, Pre-orbital cellulitis, Orbital cellulitis, Endogenous endophthalmitis, Exogenous endophthalmitis, Keratitis, Viral retinitis, Rosacea, Dacrocystitis, Blepharitis, Toxoplasmosis, Toxocariasis, Surgical prophylaxis

Microbiology

1. Purpose

1.1. This document sets out Northern Devon Healthcare NHS Trust’s best practice guidelines for appropriate microbiological investigation and antimicrobial prescribing in adult patients with Ophthalmological infection.

1.2. This guideline applies to all adults and must be adhered to. Special considerations exist for pregnant and breastfeeding patients; liaise with specialist clinicians as appropriate in these cases. See separate guidance for paediatric patients.

1.3. Non-compliance with this guideline may be for valid clinical reasons only. The reason(s) for non-compliance must be documented clearly in the patient’s notes.

1.4. This guideline is primarily aimed at all prescribing teams but other staff (e.g. nursing staff, pharmacists) may need to familiarise themselves with some aspects of the guideline.

1.5. Implementation of this guideline will ensure that:

 Ophthalmological infection is managed according to current evidence and standards of practice in the wider healthcare community.  A standard of care is specified to facilitate a consistent approach between ophthalmology, microbiology and pharmacy in terms of patient management, specimen processing and drug availability.

2. Responsibilities

2.1. Responsibility for education and training lies with the Lead Consultant Microbiologist for Antibiotic Stewardship. It will be provided through formal study days and informal training on the ward.

2.2. The author will be responsible for ensuring the guidelines are reviewed and revisions approved by the Drug and Therapeutics Group in accordance with the Document Control Report.

2.3. All versions of these guidelines will be archived in electronic format by the author within the Antibiotic Stewardship policy archive.

2.4. Any revisions to the final document will be recorded on the Document Control Report.

2.5. To obtain a copy of the archived guidelines, contact should be made with the author.

2.6. Monitoring of implementation, effectiveness and compliance with these guidelines will be the responsibility of the Lead Clinician for Antibiotic Stewardship. Where non-compliance is found, the reasons for this must have been documented in the patient’s medical notes.

Microbiology

Role of Antibiotic Working Group (AWG)

2.7. The AWG is responsible for:

 Leading antibiotic guideline development and review within Northern Devon Healthcare Trust  Involving all relevant stakeholders in guideline development and review

3. Contacts

3.1. Contact numbers:

 Microbiologist Bleep 193. Via switchboard out of hours.  Antibiotic Pharmacist Bleep 029 (Mon-Fri only)  On call Ophthalmologist Via switchboard out of hours.

4. Management of Ophthalmological infections

4.1. See appendices

5. Monitoring Compliance with and the Effectiveness of

the Guideline

Suggested audit criteria

5.1. The following could be used:

 Required specimens to be sent as per guideline 100%  Antibiotic (topical and systemic) used as per guideline or microbiology advice 100%

Process for Implementation and Monitoring Compliance and

Effectiveness

5.2. Incidents involving ophthalmic infection should be reported according to the Trust’s Incident Reporting Policy. Critical incident reports relating to ophthalmologic infection will be collated by the Antibiotic Pharmacist. Results will be reported on an annual basis to the Drug and Therapeutics Group.

Microbiology

7. References

7.1. General

Denniston and Murray [Eds.]. 2018. 4th^ Edition Oxford Handbook of Ophthalmology. Via Trust intranet. http://oxfordmedicine.com/view/10.1093/med/9780198804550.001.0001/med- 9780198804550

Clinical guidelines for Consultant Ophthalmologists – department utilises this reference source as their gold standard

7.2. Conjunctivitis

Clinical Knowledge Summary. Infective Conjuncitivitis. https://cks.nice.org.uk/conjunctivitis-infective Last revised August 2015. Accessed 6/6/

The College of Optometrists. Clinical Management Guideline: Conjunctivitis. https://www.college-optometrists.org/guidance/clinical-management- guidelines/conjunctivitis-bacterial-.html Last reviewed June 2014. Accessed 6/6/17.

7.3. Peri- and orbital cellulitis

Papier A, Tuttle DJ, Mahar TJ. Differential diagnosis of the swollen red eyelid. Am Fam Physician. 2007 76(12):1815-24.

Spellberg B, et al. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis. 2009 Jun 15;48(12):1743-

The College of Optometrists. 2015. Cellulitis, preseptal and orbital

7.4. Endophthalmitis

Riddell J 4th, Comer GM, Kauffman CA. (2011) Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis.52, 648-53.

7.5. Keratitis

M Daniell. Overview: Initial antimicrobial therapy for microbial keratitis Br J Ophthalmol. 2003 September; 87(9): 1172– 1174

The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. Ophthalmology. 1997 Nov;104(11):1902-9.

Wilhelmus K. 2009. Therapeutic interventions for HSV epithelial keratitis. Cochrane Rev.

Microbiology

The College of Optometrists. 2016. Clinical Guideline: Microbial keratitis (bacterial, fungal) v.10. https://www.college-optometrists.org/guidance/clinical- management-guidelines/microbial-keratitis-bacterial-fungal-.html

The College of Optometrists. 2015. Clinical Guideline: Keratitis (marginal) v.9. https://www.college-optometrists.org/guidance/clinical-management- guidelines/keratitis-marginal-.html

The College of Optometrists. 2016. Clinical Guideline: Herpes Simplex Keratitis v.11. https://www.college-optometrists.org/guidance/clinical- management-guidelines/herpes-simplex-keratitis-hsk-.html

The College of Optometrists. 2015. Clinical Guideline: Microbial Keratitis (Acanthameoba Sp.) v.10. https://www.college- optometrists.org/guidance/clinical-management-guidelines/microbial-keratitis- acanthamoeba-sp-.html

Balderson, DE; Cai, G; Fries, MA; Kleinman, DM; McLaughlin, MM; Trivedi, TM; Wurzelmann, JI; Young, SB. 2015. A systematic review and meta- analysis to compare the efficacy of acyclovir 3% ophthalmic ointment to idoxuridine in curing herpetic keratitis by Day 7 of treatment. BMC Ophthalmology 17;15:42. doi: 10.1186/s12886-015-0022-2.

NICE. 2016. CKS Topics: Shingles. https://cks.nice.org.uk/shingles#!scenario:

7.6. Blepharitis

Clinical Knowledge Summaries. https://cks.nice.org.uk/blepharitis Last revised October 2015. Accessed 5th^ June 2017.

The College of Optometrists. Clinical Management Guidelines: Blepharitis (Lid Margin Disease). https://www.college-optometrists.org/guidance/clinical- management-guidelines/blepharitis-lid-margin-disease.html Last revised Dec

7.7. Viral retinitis

Wong R, Pavesio CE, Laidlaw DA, Williamson TH, Graham EM, Stanford MR. (2010) Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome. Ophthalmology. 117, 556-60.

7.8. Toxocariasis

Microbiology

SIGN. 2014. 104: Antibiotic Prophylaxis in Surgery. http://www.sign.ac.uk/assets/sign104.pdf (intracameral ceftazidime and vanc, pre and post-surgery if organic matter left)

The Royal College of Emergency Medicine. 2017. Best Practice Guideline: Pharmacological Agents for Procedural Sedation and Analgesia in the Emergency Department. http://www.rcem.ac.uk/docs/College%20Guidelines/Pharmacological%20Age nts%20for%20Procedural%20Sedation%20and%20Analgesia%20(Jan% 17%20Revised).pdf (ketamine contraindicated for globe injury)

Wilson, A; Soar, J. 2000. ANAESTHESIA FOR EMERGENCY EYE SURGERY. Update in Anaesthesia 11: 46-50. http://e-safe- anaesthesia.org/e_library/06/Anaesthesia_for_emergency_eye_surgery_Upd ate_2000.pdf

7.11. Surgical prophylaxis

Sharifi E, Porco TC, Naseri A. Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. Ophthalmology. 2009 Oct;116(10):1887-

7.12. Acanthamoeba

Royal College of Optometrists. 2016. Microbial Keratitis (Acanthamoeba sp.) https://www.college-optometrists.org/guidance/clinical-management- guidelines/microbial-keratitis-acanthamoeba-sp-.html

Cochrane Eyes and Vision Group. 2015. Medical Interventions for Acanthaemoeba Keratitis. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010792.pub2/full

Seas and Bravo. 2017. Free-living amebas and Prototheca. Uptodate.com https://www.uptodate.com/contents/free-living-amebas-and- prototheca?source=search_result&search=acanthamoeba%20keratitis&select edTitle=1~

8. Associated Documentation

 Incident reporting policy  Antibiotic guidelines for management of severe sepsis and septic shock  Antibiotic prescribing policy  Penicillin allergy policy  Antibiotic guidelines for surgical prophylaxis

Microbiology

9. Appendix 1 - Blepharitis

9.1. Name of guideline on app

Blepharitis 9.2. Location on app

Infection Adult Treatment Ophthalmology Blepharitis 9.3. Header

Anterior blepharitis primarily affects the lashes, and posterior blepharitis involves the meibomian glands. The mainstay of treatment is maintenance of good lid hygiene, even in the absence of active symptoms. For further information on clinical topics in ophthalmology, see the most up to date version of the Oxford Handbook of Ophthalmology (available via library website on BOB).

9.4. Diagnosis and Differentials [open/closed]

Predisposing factors

 Dry eye disease is present in:  50% of people with staphylococcal blepharitis  25-40% of people with seborrhoeic blepharitis  Patients with seborrhoeic blepharitis may also have seborrhoeic dermatitis (eg. on the scalp)  A significant association has been found between Demodex mite infestation and blepharitis. Demodex folliculorum is an ectoparasite that occurs normally in the lash follicles  Long-term contact lens wear  Ocular rosacea (a cause of posterior marginal blepharitis)

Symptoms

Blepharitis may be asymptomatic. Symptoms of anterior marginal blepharitis, posterior marginal blepharitis and mixed anterior and posterior marginal blepharitis are similar:

 Ocular discomfort, soreness, burning, itching  Mild photophobia  Symptoms of dry eye including blurred vision and contact lens intolerance

Microbiology

Mixed anterior and posterior marginal blepharitis

 Elements of both conditions are present

All of these conditions are typically bilateral, and chronic or relapsing

Differential diagnosis (see also red flags)

 Allergy  Serious eye conditions - in “Watch Out For (red flags)” section below

9.5. Always Remember To… [open/closed]

 Counsel the patient on good hygiene measures, mainstay of treatment is non-pharmacological.  Advise avoidance of contact lenses, depending on symptoms it may be preferable to wear spectacles for a time.  Advise avoidance of eye cosmetics until symptoms resolve. Old make- up and cleanser should be disposed of, and brushes/applicators cleaned. Be aware that some occupations require the use of cosmetics, and this may result in the need for a “fit note”.  Any open containers of pre-existing eye-drops should be disposed of via the patient’s local Pharmacy and new bottles provided when blepharitis treatment commences. Ensure none of the prescribed ocular medicines are the cause of the ophthalmic irritation. 9.6. Watch Out For (red flags)… [open/closed]

Important differential diagnoses  Dermatoconjunctivitis medicamentosa (brimonidine, atropine, neomycin, benzalkonium chloride, phenylmercuric nitrate and lanolin are considered more likely to cause this)  Dacryocystitis  Parasitic infestation (e.g. Phthirus pubis infestation)  Preseptal cellulitis  Herpes (simplex or zoster)  Meibomian gland carcinoma (usually unilateral)

Red flag symptoms

 Corneal erosion  Marginal keratitis  Ocular surface scarring  Ocular neovascularisation and pannus  Mild papillary conjunctivitis  Visual loss  Painful red eye  Recent ocular procedure  Previous blepharitis treatment failure, or worsening symptoms

Microbiology

9.7. General Interest [closed]

 Blepharitis is a chronic, intermittent condition, and although it cannot be cured, symptoms can usually be controlled with self-care measures.  Compliance with treatment, especially eyelid hygiene, is essential, and this should be continued even when symptoms are well controlled.  Complications, such as vision loss, are rare

9.8. Treatment [closed]

 Anterior blepharitis

First line

Twice daily lid hygiene:

Apply a warm compress to the closed eyelids for 5–10 minutes (e.g. a clean cloth warmed with water), then clean the eyelid by wetting a cloth or cotton bud with cleanser (for example, baby shampoo diluted 1:10 with warm water) and wiping along the lid margins. Eyelid scrubs or wipes can be used to clear away the scales on the lashes.

Second line – after failure of conservative methods (choose appropriate antibiotic depending on previous treatment, or causative organism)

(Preferred option) Chloramphenicol 0.5% eyedrops, or 1% eye ointment Instil 1 drop, or apply ointment 3-4 times daily for 6 weeks into affected eye(s)

And if needed

Topical corticosteroid eyedrop if advised by Consultant Ophthalmologist- FML or loteprednol (prednisolone 0.1% drops for paediatric patients)

Or

(Less Gram negative cover) Fusidic acid 1% eyedrops Instil 1 drop BD for 6 weeks into affected eye(s).

And if needed

Topical corticosteroid eyedrop if advised by Consultant Ophthalmologist- FML or loteprednol (prednisolone 0.1% drops for paediatric patients)

Or (paediatrics) Azithromycin 0.15% eyedrops

Microbiology

10. Appendix 2 – Conjunctivitis

10.1. Name of guideline on app

Conjunctivitis 10.2. Location on app

Infection Adult Treatment Ophthalmology Conjunctivitis 10.3. Header

Conjunctivitis is the commonest cause of red eye. Most infections are self-limiting. Consider a delayed prescription. For further information on clinical topics in ophthalmology, see the most up to date version of the Oxford Handbook of Ophthalmology (available via library website on BOB).

10.4. Diagnosis and Differentials [open/closed]

Predisposing Factors  Contamination of the conjunctival surface  Superficial trauma  Contact lens wear (NB infection may be Gram – ve)  Secondary to viral conjunctivitis  Recent cold, upper respiratory tract infection (viral conjunctivitis more likely), or sinusitis  Diabetes (or other disease compromising the immune system)  Steroids (systemic or topical, compromising ocular resistance to infection)  Blepharitis (or other chronic ocular inflammation)  Children and the elderly have an increased risk of infective conjunctivitis (NB Bacterial conjunctivitis in the first 28 days of life is a serious condition that must be referred urgently to the ophthalmologist.)

Symptoms  Acute onset of:  Redness – maximal in fornices, sometimes mild papillary reaction in Tarsal conjunctiva  Discomfort, usually described as burning or grittiness  Purulent or mucopurulent discharge (may cause temporary blurring of vision)  Crusting of lids (often stuck together after sleep and may have to be bathed open

Microbiology

 Usually bilateral – one eye may be affected before the other (by one or two days)  Usually no involvement of cornea (confirmed by fluorescein drop staining)  Usually no pre-auricular lymphadenopathy  Usually no pain – if painful red eye refer to ophthalmology ugently  Usually no change in vision when discharge is cleaned away – if visual disturbance persists, refer to ophthalmology urgently  Usually no photophobia – if present, consider uveitis and refer to ophthalmology urgently  Differential diagnosis (see also red flags)  Epidemic keratoconjunctivitis (e.g. adenovirus)  Herpes (simplex or zoster)  Chlamydial infection  Allergy  Other causes of acute red eye (including uveitis and glaucoma)  Serious eye conditions - in “Watch Out For (red flags)” section below

10.5. Always Remember To… [open/closed]

 Counsel the patient on good hygiene measures, for mild infections mainstay of treatment is non-pharmacological. Avoid towel-sharing and ensure good hand hygiene to prevent cross-infection with others in the household/workplace.  Exclusion from school/workplace is only necessary if the patient is part of a wider outbreak. Refer to Public Health, contact Microbiologist on call, or Infection Prevention and Control during office hours for advice.  Advise avoiding contact lens use until symptoms are resolved. The patient should dispose of reusable contact lenses and thoroughly clean their maintenance equipment.  Advise avoidance of eye cosmetics until symptoms resolve. Old make- up and cleanser should be disposed of, and brushes/applicators cleaned. Be aware that some occupations require the use of cosmetics, and this may result in the need for a “fit note”.  Open containers of pre-existing eye-drops should be disposed of via the patient’s local Pharmacy and new bottles provided when conjunctivitis treatment commences. Ensure none of the prescribed ocular medicines are the cause of the ophthalmic irritation.  Microbiological sampling:  Standard charcoal swabs are rarely of value.  Viral swabs for adenoviral PCR may be helpful if there is diagnostic doubt  If taking swabs for Chlamydia, ensure that pus is removed first and that cellular material is obtained. Use a standard Chlamydia swab. NB Chlamydia swabs cannot be processed after fluorescein staining. If fluorescein has been used ensure extensive flushing with normal saline before taking swab.

Microbiology

NB. Fusidic acid has less Gram negative activity than chloramphenicol

Chlamydia conjunctivitis

Refer to GUM guidance, and treat as for genital infection

Gonococcal conjunctivitis

Ceftriaxone 2g IV single dose*

*If allergy to cephalosporins, discuss with Microbiology

Viral conjunctivitis

See keratitis guidance

10.9. If No Better… [closed]

 Consider deeper infection / inflammation  Consider non-infectious causes  Chlamydia  Compliance with treatment and hygiene advice  10.10. Other Relevant Guidelines [closed]

Keratitis

10.11. Organisms and Sensitivities [closed]

Common organisms and sensitivity to chloramphenicol topical therapy:

H.influenzae – 100%

Strep. Pneumonia – 100%

S. aureus – 97%

Viruses (esp. Adenovirus) – not treated with chloramphenicol

Rare causes: Chlamydia trachomatis, N.gonorrhoea

10.12. Version Control [closed]

Antibiotic Guidelines for Ophthalmology v2.0 160519

11. Appendix 3 - Dacrocystitis

11.1. Name of guideline on app

Dacrocystitis

Microbiology

11.2. Location on app

Infection Adult Treatment Ophthalmology Dacrocystitis 11.3. Header

Dacrocystitis is inflammation associated with bacterial infection of the nasolacrimal sac. Common organisms include Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, and more rarely Pseudomonas spp. For further information on clinical topics in ophthalmology, see the most up to date version of the Oxford Handbook of Ophthalmology (available via library website on BOB).

11.4. Diagnosis and Differentials [open/closed]

Predisposing factors

 Maxillary sinusitis  Trauma to adjacent tissues  Nasal or sinus surgery  Congenital or other obstruction of nasolacrimal duct  Most commonly seen in infants and post-menopausal women, relatively rare in other groups  Signs and Symptoms  Sudden onset  Pain  Red, tender swelling over lacrimal sac and extending around the orbit  Watering eyes (epiphora)  Fever/rigors  Purulent discharge expressible from one or both puncta when pressure is applied over the lacrimal sac (NB likely to be painful for patient)  Sac may discharge on to skin surface (NB important to distinguish between acute dacryocystitis, in which sac is full of pus, and mucocoele in which sac is filled with mucoid material in the absence of infection)  Patients may present with conjunctivitis and preseptal cellulitis. Rarely, the infection extends behind the septum, causing orbital cellulitis  Some patients go on to develop chronic dacrocystitis, which may or may not be infectious. Referral for surgical management may be appropriate in these cases.  Differential diagnosis (see also red flags)  Facial cellulitis